loading page

Dupilumab eliminated airway hyperresponsiveness in a 12-year-old boy with severe atopic asthma.
  • +1
  • Kazuyo Kuzume,
  • Yu Kuwabara,
  • Kiriko Tokuda,
  • Kenji Matsumoto
Kazuyo Kuzume
Ehime University Graduate School of Medicine
Author Profile
Yu Kuwabara
Ehime University Graduate School of Medicine
Author Profile
Kiriko Tokuda
Yawatahama City General Hospital
Author Profile
Kenji Matsumoto
National Research Institute for Child Health and Development
Author Profile

Peer review status:UNDER REVIEW

08 Oct 2021Submitted to Pediatric Allergy and Immunology
13 Oct 2021Reviewer(s) Assigned